MoneyWorks4Me

Celestial Biolabs reports Profit after tax of Rs -0.32 Mln, in the September 2023 quarter

30 Sep 2023 Evaluate
A decrease in the sales to Rs. 0.36 millions was observed for the quarter ended September 2023. The sales stood at Rs. 0.42 millions during the similar quarter previous year.The Net Loss for the quarter ended September 2023 is Rs. -0.32 millions as compared to Net Loss of Rs. -0.82 millions of corresponding quarter ended September 2022 Operating profit Margin for the quarter ended September 2023 improved to -0.27% as compared to -0.74% of corresponding quarter ended September 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 0.36 0.42 -14.29 0.36 0.97 -62.89 1.69 1.48 14.19
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT -0.27 -0.74 -63.51 -0.27 -1.68 -83.93 -5.41 -3.79 42.74
Interest 0.00 0.01 -100.00 0.00 0.01 -100.00 0.02 0.00 0.00
PBDT -0.27 -0.75 -64.00 -0.27 -1.69 -84.02 -5.43 -3.79 43.27
Depreciation 0.05 0.07 -28.57 0.05 0.14 -64.29 0.28 0.30 -6.67
PBT -0.32 -0.82 -60.98 -0.32 -1.83 -82.51 -5.71 -4.09 39.61
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.32 -0.82 -60.98 -0.32 -1.83 -82.51 -5.71 -4.09 39.61
Equity 225.86 225.86 0.00 225.86 225.86 0.00 225.86 225.86 0.00
PBIDTM(%) -75.00 -176.19 -57.43 -75.00 -173.20 -56.70 -320.12 -256.08 25.01
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..